Get the Stockscreener App
136.45
0.54%
0.73
Pre-market:
136.06
-0.39
-0.29%
State Street Spdr S P Biotech Etf stock is traded at $136.45, with a volume of 8.55M.
It is up +0.54% in the last 24 hours and up +12.00% over the past month.
See More
Previous Close:
$135.72
Open:
$136.37
24h Volume:
8.55M
Relative Volume:
0.89
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+4.44%
1M Performance:
+12.00%
6M Performance:
+25.91%
1Y Performance:
+78.27%
1-Day Range:
$134.45
$137.50
1-Week Range:
$128.76
$137.50
52-Week Range:
$73.94
$137.50
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Name
State Street Spdr S P Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
136.45 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
345.24 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
699.94 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
703.19 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
278.28 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
637.40 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Stock (XBI) Latest News
Tech Leads, Dow Lags As Oil Holds Near $92: What's Moving Markets Wednesday? - Benzinga
Citigroup, Morgan Stanley, CBRE Group and more on CNBC's 'Final Trades' - MSN
Citigroup, Morgan Stanley, CBRE Group And More On CNBC's 'Final Trades' - Benzinga
Roundview Capital LLC's State Street SPDR S&P Biotech ETF(XBI) Holding History - GuruFocus
TD (NYSE: TD) offers callable contingent‑interest notes linked to KRE, KWEB, XBI - Stock Titan
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo! Finance Canada
XBI vs. IBB: The Biotech ETF Showdown That Analysts Say Has a Clear Winner in 2026 - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) Stock Price, News, Quote & History - Yahoo! Finance Canada
Neurocrine Buys Soleno To Tap High-Growth Rare Disease MarketNeurocrine Biosciences (NASDAQ:NBIX), Sol - Benzinga
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It. - 24/7 Wall St.
$1000 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth This Much Today - Sahm
First Trust NYSE Arca Biotechnology Index Fund (FBT) stock price, news, quote and history - Yahoo Finance Singapore
VanEck Biotech ETF (BBH) stock price, news, quote and history - Yahoo Finance Singapore
Direxion Daily S&P Biotech Bull 3X Shares (LABU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead - 24/7 Wall St.
Trade State Street SPDR S&P Biotech ETFXBI CFD - Capital.com
Atika Capital Management LLC's State Street SPDR S&P Biotech ETF(XBI) Holding History - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
ETFs Investing in Novavax, Inc. Stocks - TradingView
ETFs Investing in Moderna, Inc. Stocks - TradingView
ADMA Jumps 15% in Late-Day Rally: Biotech Market Turbulence Escalates Amid Options Trading Momentum - Bitget
Is State Street SPDR S&P Biotech ETF (XBI) a strong ETF right now? - MSN
Tango Therapeutics Ignites: 11% Surge to Historic Highs Signals Biotech Power Play - Bitget
US defense giant taps Israeli drone navigation tech built for jammed battlefields - The Jerusalem Post
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Scholar Rock Holding Surges 10.6% in Intraday Trade – What’s Behind the Volatility? - Bitget
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - The Motley Fool
Sector alert: 4 healthcare ETFs poised for explosive growth now - MSN
Biotech ETF with a twist: Defiance to donate initial advisory profits to autism causes - MSN
Autocall Notes Linked to Nasdaq-100 & ETFs (AMJB) — $3M Offering - Stock Titan
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - sharewise.com
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom - Bitget
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
XBI: Biotech M&A Has Been Hot, But Price Trends Have Cooled - Seeking Alpha
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress - Benzinga
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
JPMorgan (AMJB) prices callable contingent‑interest notes linked to SCZ/XBI/KRE - Stock Titan
State Street SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
This 1 ETF Keeps Outperforming the S&P 500- Expect it to Win Again This Year - AOL.com
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars - Benzinga
A Golden Age of Biotech Is Upon Us, Thanks to AI. This ETF Offers 40% Upside. - Barron's
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak ProofPTC Therapeutics (NASDAQ:PTCT) - Benzinga
Do Wall Street Analysts Like Incyte Corporation Stock? - inkl
Do financial experts on Wall Street have a favorable opinion of Incyte Corporation shares? - Bitget
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now - The Motley Fool
State Street Spdr S P Biotech Etf Stock (XBI) Financials Data
There is no financial data for State Street Spdr S P Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.45%
1.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):